HHS Recommends Easing Marijuana Restrictions

Recommendation prompts the DEA to conduct a final review for reschedulization. The Department of Health and Human Services (HHS) has announced that the department recommends the reclassification of…

Read More

White House Advisor Certain of Legality of Drug Price Negotiations

Pharmaceutical companies challenge the administration in court over negotiations by Medicare. White House Domestic Policy Council Director Neera Tanden expressed confidence in the legality of Medicare’s new program…

Read More

Administration Announces Prescriptions Available for Price Negotiations

Ten drugs will be negotiated, with new pricing as of 2026. President Biden’s administration has announced the first 10 prescription drugs available for Medicare price negotiations. The pharmaceuticals…

Read More

Appeals Court Rules to Limit Access to Abortion Drug

Mifepristone was not ordered to be removed from the market, and the case goes to Supreme Court. The 5th Circuit Court of Appeals ruled that the Food and…

Read More

FDA and DEA Address Stimulant Medicine Shortage

Agency heads request an increase from manufacturers and for healthcare providers to slow demand. The Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) are taking steps…

Read More

FDA Approves 2nd Opioid Reversal Drug for Over-The-Counter Use

The nasal spray will be available prescription-free by next year. The Food and Drug Administration (FDA) recently approved the opioid overdose reversal drug RiVive for over-the-counter sale, making…

Read More

Federal Judge Allows Most Provisions of NC Abortion Ban

The only measure blocked by the court pertains to early pregnancy. District Judge Catherine Eagles ruled that most of North Carolina’s 12-week abortion law can go into effect…

Read More

DOJ Addresses Healthcare Fraud Across the Nation

Justice Department names 78 defendants in case of false billing to Medicare. The Department of Justice (DOJ) recently released dozens of federal and local criminal charges that address…

Read More

FTC Appeals Dismissal of Antitrust Case to 2nd Circuit

Maintains “pay-for-delay” practice by a pharmaceutical company violates antitrust law. The Federal Trade Commission (FTC) has appealed a federal district court’s dismissal of an antitrust case. The commission…

Read More

FTC Expands Study into Prescription Drug Intermediaries

Group purchasing organizations are required to provide information on business practices. The Federal Trade Commission (FTC), as part of its ongoing study of pharmacy benefit managers (PBMs) and…

Read More
Back to top
FE3